Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06558188 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Combined Anabolic Therapy

Study acronym: CAT
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion moved earlier from Dec 30, 2027 to Nov 2, 2027 Completion moved earlier from Apr 1, 2028 to Nov 19, 2027 · Eligibility criteria expanded, about 12 words Show 2 more changesShow less
    • Completion moved earlier from Apr 1, 2028 to Nov 19, 2027
    • Eligibility criteria expanded, about 12 words
  2. Primary completion date: Apr 30, 2027 to Dec 30, 2027 Completion date: Jul 1, 2027 to Apr 1, 2028v4 Show 1 more changeShow less
    • Completion date: Jul 1, 2027 to Apr 1, 2028
  3. Trial status: Not Yet Recruiting to Recruiting Primary completion date: Apr 1, 2027 to Apr 30, 2027 · Completion date: Jan 1, 2028 to Jul 1, 2027 · Start date changed from estimate of Apr 1, 2025 to Feb 3, 2025 · 1 morev3 Show 4 more changesShow less
    • Primary completion date: Apr 1, 2027 to Apr 30, 2027
    • Completion date: Jan 1, 2028 to Jul 1, 2027
    • Start date changed from estimate of Apr 1, 2025 to Feb 3, 2025
    • Site details revised
  4. Enrollment target: 46 to 50 Study sites: 0 to 1 · Collaborators expanded, about 10 wordsv2 Show 2 more changesShow less
    • Study sites: 0 to 1
    • Collaborators expanded, about 10 words

    See this version in full on ClinicalTrials.gov ↗

  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
In this research study the study investigators want to learn more about the effect of two different FDA-approved medication regimens in the treatment of postmenopausal osteoporosis.
Trial Details
NCT Number NCT06558188
Lead Sponsor Massachusetts General Hospital
Collaborators: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Conditions Osteoporosis, Postmenopausal, Osteoporosis
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov